Clinical Trial

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Name: A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® — clinical trial record (NCT07062978)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind comparative study to valuating the efficacy and safety of QL1206 and Prolia® in postmenopausal women with osteoporosis at high risk of fracture.

Trial Details

NCT Number	NCT07062978
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Postmenopausal Women With Osteoporosis at High Risk of Fracture
Enrollment	278 participants
Start Date	2025-06-27
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-14